AZN 6-K: Fda approval

Filed with the SEC on · accession 0001654954-26-009804

AZN filed a 6-K (foreign company report) with the SEC on Nov 16, 2026. AstraZeneca's Alexion unit received European Commission approval for Klygefa (gefurulimab) for the treatment of adults with generalised myasthenia gravis (gMG) who are anti-AChR antibody positive.

Summary of the filing

AstraZeneca's Alexion unit received European Commission approval for Klygefa (gefurulimab) for the treatment of adults with generalised myasthenia gravis (gMG) who are anti-AChR antibody positive. The approval was based on positive Phase III PREVAIL trial results showing rapid and sustained disease control with once-weekly subcutaneous self-administration.

Key details

IssuerAstraZeneca PLC
SubsidiaryAlexion, AstraZeneca Rare Disease
Chief executive officer, alexionMarc Dunoyer
Director department of neurology, bg university hospital bergmannsheil bochumTobias Ruck
President, european myasthenia gravis associationLutgarde Allard

✦ Ask GOAX AI about this filing — what it means for AZN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AZN?

Click here

Frequently asked questions

What did AZN file with the SEC on Nov 16, 2026?

AZN filed a 6-K (Fda approval). AstraZeneca's Alexion unit received European Commission approval for Klygefa (gefurulimab) for the treatment of adults with generalised myasthenia gravis (gMG) who are anti-AChR antibody positive. The approval was based on positive Phase III PREVAIL trial results showing rapid and sustained disease control with once-weekly subcutaneous self-administration.

What does a fda approval mean for AZN stock?

For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.

How do I read a 6-K?

How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.

Other AZN SEC filings

Get alerts when AZN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days